Abstract
The present disclosure provides a biodelivery platform for the oral administration of molecular cargo.
Full Text
What is claimed is:
The present disclosure provides a biodelivery platform for the oral administration of molecular cargo.
Timeline
Filed
03/03/2026Published
06/25/2026Granted
Not AvailableIPC Codes(3)
A61K 47/64:Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K 47/65)
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 31/198:Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K 31/205; proline A61K 31/401; tryptophan A61K 31/405; histidine A61K 31/4172; peptides not degraded to individual amino acids A61K 38/00)